Transaction in Own Shares

AI SummaryClose X

Hikma Pharmaceuticals Plc has purchased 1,001,184 ordinary shares as part of its $250 million share repurchase program, with the shares intended for cancellation. Since the program's launch on February 26, 2026, Hikma has bought back a total of 4,880,237 ordinary shares for £61.7 million. Following these transactions, the company holds 12,833,233 ordinary shares in treasury, with 217,006,216 ordinary shares in issue, resulting in a total of 217,006,216 voting rights.

Disclaimer*

UK 100

Latest directors dealings